Literature DB >> 25189655

RSV infection among children born moderately preterm in a community-based cohort.

Rolof G P Gijtenbeek1, Jorien M Kerstjens, Sijmen A Reijneveld, Eric J Duiverman, Arend F Bos, Elianne J L E Vrijlandt.   

Abstract

UNLABELLED: We aimed to determine the rates of proven respiratory syncytial virus (RSV) hospitalization and disease severity among children born moderately preterm (MP, gestational age [GA] 32-36 weeks, n = 964), children born full-term (FT, GA 38-42 weeks, n = 572), and children born early preterm (EP, GA <32 weeks, n = 524). Our second aim was to identify risk factors for RSV hospitalization among MP. We extracted data from parental questionnaires and medical records, retrieved from a community-based cohort of children aged 43-49 months. The RSV hospitalization rates of MP were higher than FT (3.9 vs. 1.2 %, relative rate 3.2; 95 % confidence interval (CI) 1.4-7.1) and equal to EP (3.9 vs. 3.2 %, relative rate 1.2; 95 % CI 0.7-2.1). MP were hospitalized at an earlier age than EP. Disease severity (based on the type of treatment and hospitalization length) was equal in all groups. Risk factors for RSV hospitalization in MP were younger age and lower birth weight. In multivariable analyses, shorter GA and passive smoking independently increased the likelihood of RSV hospitalization in MP.
CONCLUSION: The rates of hospitalization due to proven RSV infection are higher in MP than FT and not different between MP and EP. No difference in disease severity was observed. Among MP, the rates of RSV hospitalization are higher for lower GA and when exposed to passive smoking.

Entities:  

Mesh:

Year:  2014        PMID: 25189655     DOI: 10.1007/s00431-014-2415-2

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  43 in total

Review 1.  Are late preterm infants as susceptible to RSV infection as full term infants?

Authors:  Bernhard Resch; Bosco Paes
Journal:  Early Hum Dev       Date:  2011-01-26       Impact factor: 2.079

2.  Immunoglobulin profile of the preterm baby.

Authors:  S P Conway; P R Dear; I Smith
Journal:  Arch Dis Child       Date:  1985-03       Impact factor: 3.791

Review 3.  Respiratory syncytial virus infection.

Authors:  E A Simoes
Journal:  Lancet       Date:  1999-09-04       Impact factor: 79.321

4.  Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany.

Authors:  Johannes G Liese; Eva Grill; Birgit Fischer; Irmgard Roeckl-Wiedmann; David Carr; Bernd H Belohradsky
Journal:  Eur J Pediatr       Date:  2003-03-01       Impact factor: 3.183

5.  Moderately preterm children have more respiratory problems during their first 5 years of life than children born full term.

Authors:  Elianne J L E Vrijlandt; Jorien M Kerstjens; Eric J Duiverman; Arend F Bos; Sijmen A Reijneveld
Journal:  Am J Respir Crit Care Med       Date:  2013-06-01       Impact factor: 21.405

6.  Risk factors for respiratory syncytial virus bronchiolitis hospital admission in New Zealand.

Authors:  K Grimwood; C Cohet; F J Rich; S Cheng; C Wood; N Redshaw; C W Cunningham; N Pearce; J R Kirman
Journal:  Epidemiol Infect       Date:  2008-01-04       Impact factor: 2.451

7.  The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation.

Authors:  Barbara J Law; Joanne M Langley; Upton Allen; Bosco Paes; David S C Lee; Ian Mitchell; John Sampalis; Hervé Walti; Joan Robinson; Karel O'Brien; Carina Majaesic; Georges Caouette; Lyne Frenette; Nicole Le Saux; Brian Simmons; Sharon Moisiuk; Koravanagattu Sankaran; Cecil Ojah; Avash J Singh; Marc H Lebel; Godfrey S Bacheyie; Heather Onyett; Andrea Michaliszyn; Patricia Manzi; Diana Parison
Journal:  Pediatr Infect Dis J       Date:  2004-09       Impact factor: 2.129

8.  Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis--a prospective birth-cohort study.

Authors:  Beatrijs L P Bloemers; A Marceline van Furth; Michel E Weijerman; Reinoud J B J Gemke; Chantal J M Broers; Kimberly van den Ende; Jan L L Kimpen; Jan L M Strengers; Louis J Bont
Journal:  Pediatrics       Date:  2007-10       Impact factor: 7.124

Review 9.  Respiratory syncytial virus bronchiolitis: prevention and treatment.

Authors:  Tina E Faber; Jan L L Kimpen; Louis J Bont
Journal:  Expert Opin Pharmacother       Date:  2008-10       Impact factor: 3.889

10.  Maternal asthma and maternal smoking are associated with increased risk of bronchiolitis during infancy.

Authors:  Kecia N Carroll; Tebeb Gebretsadik; Marie R Griffin; William D Dupont; Edward F Mitchel; Pingsheng Wu; Rachel Enriquez; Tina V Hartert
Journal:  Pediatrics       Date:  2007-06       Impact factor: 7.124

View more
  14 in total

1.  Letters to the Editor.

Authors:  I Mitchell; B Paes; K Lanctot; Rupesh Chawla; Aaron Chiu; Marianna Mitchell; Cecil Ojah; April Price; Sandra Seigel; Amanda Symington
Journal:  Paediatr Child Health       Date:  2015 Nov-Dec       Impact factor: 2.253

2.  The Burden of Severe Respiratory Syncytial Virus Disease Among Children Younger than 1 Year in Central and Eastern Europe.

Authors:  Olivier Van de Steen; Farzaneh Miri; Marta Gunjaca; Vanesa Klepac; Baerbel Gross; Gerard Notario; Colleen M Wegzyn
Journal:  Infect Dis Ther       Date:  2016-05-12

Review 3.  Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries.

Authors:  Louis Bont; Paul A Checchia; Brigitte Fauroux; Josep Figueras-Aloy; Paolo Manzoni; Bosco Paes; Eric A F Simões; Xavier Carbonell-Estrany
Journal:  Infect Dis Ther       Date:  2016-08-01

Review 4.  Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis.

Authors:  Renato T Stein; Louis J Bont; Heather Zar; Fernando P Polack; Caroline Park; Ami Claxton; Gerald Borok; Yekaterina Butylkova; Colleen Wegzyn
Journal:  Pediatr Pulmonol       Date:  2016-10-14

5.  Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants.

Authors:  Ahva Shahabi; Desi Peneva; Devin Incerti; Kimmie McLaurin; Warren Stevens
Journal:  Pharmacoecon Open       Date:  2018-03

6.  Hospitalisation of late preterm infants due to lower respiratory tract infections in Lithuania, Latvia, and Estonia: incidence, disease severity, and risk factors.

Authors:  Nijolė Drazdienė; Rasa Tamelienė; Daiga Kviluna; Pille Saik; Ervin Saik; Jolanta Zaikauskienė
Journal:  Acta Med Litu       Date:  2018

7.  Respiratory Syncytial Virus Prophylaxis in Infants With Congenital Diaphragmatic Hernia in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab, 2005-2017.

Authors:  Doyoung Kim; Mahwesh Saleem; Bosco Paes; Ian Mitchell; Krista L Lanctôt
Journal:  Clin Infect Dis       Date:  2019-08-30       Impact factor: 9.079

8.  Respiratory syncytial virus acute respiratory infection-associated hospitalizations in preterm Mexican infants: A cohort study.

Authors:  Daniela Benítez-Guerra; Cecilia Piña-Flores; Miguel Zamora-López; Francisco Escalante-Padrón; Victoria Lima-Rogel; Ana María González-Ortiz; Marcela Guevara-Tovar; Sofía Bernal-Silva; Beatriz Benito-Cruz; Fernanda Castillo-Martínez; Luz E Martínez-Rodríguez; Vianney Ramírez-Ojeda; Nallely Tello-Martínez; Rodrigo Lomelí-Valdez; Jack Salto-Quintana; Sandra Cadena-Mota; Daniel E Noyola
Journal:  Influenza Other Respir Viruses       Date:  2020-01-09       Impact factor: 4.380

9.  Predictors of RSV LRTI Hospitalization in Infants Born at 33 to 35 Weeks Gestational Age: A Large Multinational Study (PONI).

Authors:  Zbyněk Straňák; Elie Saliba; Paraskevi Kosma; Klara Posfay-Barbe; Khalid Yunis; Teresa Farstad; Kristina Unnebrink; Jean van Wyk; Colleen Wegzyn; Gerard Notario; Stefanie Kalus; Fiona J Campbell
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

Review 10.  Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease.

Authors:  Josep Figueras-Aloy; Paolo Manzoni; Bosco Paes; Eric A F Simões; Louis Bont; Paul A Checchia; Brigitte Fauroux; Xavier Carbonell-Estrany
Journal:  Infect Dis Ther       Date:  2016-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.